A Service For Professionals Tuesday, October 17, 2017
Contact (202) 540-8337
Tokyo Stock Exchange News Today
A Service For Professionals Tuesday, October 17, 2017 11614 Sources 410,141,450 Articles 3,134,516 Readers
Contact (202) 540-8337

ITUS Presentation to Annual Meeting of Stockholders

/EINPresswire.com/ -- SAN JOSE, CA --(Marketwired - September 26, 2017) - ITUS Corporation (NASDAQ: ITUS) today announced that the presentation given by its Chief Executive Officer, Dr. Amit Kumar, at its Annual Meeting of Stockholders on September 22, 2017 has been placed on the Company's website. It can be viewed at http://ir.ituscorp.com/corporate-presentation.

Highlights of the presentation include:

  • The science behind Cchek™
  • The use of our proprietary Artificial Intelligence in cancer screening
  • Summary of our data, showing 90% and greater sensitivity and specificity
  • Opportunity in CAR-T therapeutics
  • Exclusive option to license certain Wistar Institute CAR-T technology
  • Potential for CAR-T effectiveness in solid tumors, as published by Wistar Institute researchers in Clinical Cancer Research, 23(2)January 15, 2017,441-453

Dr. Kumar stated, "We are very excited about the future of ITUS and look forward to providing additional updates as we continue to advance our early cancer detection technology and as we hope to expand our fight against cancer through CAR-T therapeutics."

ITUS Corporation
ITUS, a cancer-focused biotechnology company, through its wholly owned subsidiary, Anixa Diagnostics Corporation, is developing the Cchek™ platform, a series of non-invasive blood tests for the early detection of solid tumor based cancers, which is based on the body's immunological response to the presence of a malignancy. ITUS also continually examines emerging technologies in complementary or related fields for further development and commercialization. Additional information is available at www.ITUScorp.com.

Forward-Looking Statements: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect ITUS Corporation's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our most recent Annual Report on Form 10-K as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.

ITUS Corporation: FOCUSED ON INNOVATION™

Contact:
Mike Catelani
(408) 708-9808
MCatelani@ITUScorp.com

Powered by EIN Presswire